Literature DB >> 17973830

Retrograde axonal transport obstruction of brain-derived neurotrophic factor (BDNF) and its TrkB receptor in the retina and optic nerve of American Cocker Spaniel dogs with spontaneous glaucoma.

Simone Iwabe1, Norma A Moreno-Mendoza, Francisco Trigo-Tavera, Cheryl Crowder, Gustavo A García-Sánchez.   

Abstract

OBJECTIVE: To determine the degree of retrograde optic nerve axonal transport obstruction at the scleral lamina cribosa level by examining levels of brain-derived neurotrophic factor (BDNF) and its tyrosine kinase receptor type B (TrkB) in dogs presenting with high intraocular pressure. ANIMALS STUDIED: A total of 10 eyes, four normal and six glaucomatous eyes, from normal and affected American Cocker Spaniels with primary glaucoma were studied. All eyes were assessed by neuro-ophthalmic examination, tonometry, gonioscopy, slit-lamp biomicroscopy, and indirect ophthalmoscopy prior to enucleation.
METHODS: Immunocytochemistry analysis was performed to evaluate BDNF and TrkB receptor expression in retina and optic nerve in normal and glaucomatous dogs.
RESULTS: In all normal eyes BDNF immunostaining was detected in the cytoplasm of retinal ganglion cells (RGC), inner plexiform layer (IPL), inner nuclear layer (INL), nerve fiber layer (NFL), optic nerve head cells, and lamina cribosa cells. In all glaucomatous eyes BDNF was more evident in RGC, NFL and lamina cribosa cells. TrkB receptor was detected in the cytoplasm of RGC, NFL and ONH bundles in all normal eyes, and in a more intense pattern in all glaucomatous eyes.
CONCLUSIONS: BDNF retrograde axonal transport is substantially inhibited by intraocular pressure elevation. TrkB accumulation at the ONH in glaucoma suggests a role for neurotrophin deprivation in the pathogenesis of RGC death in canine glaucoma, as well as a possible paracrine and/or autocrine signaling within the lamina cribosa. Neurotrophin signaling may regulate more than neuronal development, survival and differentiation. BDNF neurotrophin and its TrkB receptor expression by lamina cribosa cells and ONH astrocytes in glaucomatous eyes may help to determine the role of these cells as a paracrine source in terms of retinal ganglion cell survival, during episodes of elevated intraocular pressure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17973830     DOI: 10.1111/j.1463-5224.2007.00504.x

Source DB:  PubMed          Journal:  Vet Ophthalmol        ISSN: 1463-5216            Impact factor:   1.644


  17 in total

1.  Retinal TrkB receptors regulate neural development in the inner, but not outer, retina.

Authors:  Ruslan N Grishanin; Haidong Yang; Xiaorong Liu; Kate Donohue-Rolfe; George C Nune; Keling Zang; Baoji Xu; Jacque L Duncan; Matthew M Lavail; David R Copenhagen; Louis F Reichardt
Journal:  Mol Cell Neurosci       Date:  2008-04-22       Impact factor: 4.314

2.  Neuroprotective effects of BDNF and GDNF in intravitreally transplanted mesenchymal stem cells after optic nerve crush in mice.

Authors:  Zong-Li Hu; Ni Li; Xin Wei; Li Tang; Ting-Hua Wang; Xiao-Ming Chen
Journal:  Int J Ophthalmol       Date:  2017-01-18       Impact factor: 1.779

3.  Protective effects of 7,8-dihydroxyflavone on retinal ganglion and RGC-5 cells against excitotoxic and oxidative stress.

Authors:  Vivek K Gupta; Yuyi You; Jonathan C Li; Alexander Klistorner; Stuart L Graham
Journal:  J Mol Neurosci       Date:  2012-10-07       Impact factor: 3.444

4.  Stem cell therapy for glaucoma: possibilities and practicalities.

Authors:  Thomas V Johnson; Natalie D Bull; Keith R Martin
Journal:  Expert Rev Ophthalmol       Date:  2011-04-01

5.  Western blot patterns of serum autoantibodies against optic nerve antigens in dogs with goniodysgenesis-related glaucoma.

Authors:  Stephanie A Pumphrey; Stefano Pizzirani; Christopher G Pirie; M Sawkat Anwer; Tanya Logvinenko
Journal:  Am J Vet Res       Date:  2013-04       Impact factor: 1.156

6.  Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma.

Authors:  Thomas V Johnson; Natalie D Bull; David P Hunt; Nephtali Marina; Stanislav I Tomarev; Keith R Martin
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-20       Impact factor: 4.799

7.  In vitro bioassay model for screening non-viral neurotrophic factor gene delivery systems for glaucoma treatment.

Authors:  Ding Wen Chen; Marianna Foldvari
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

8.  BDNF treatment and extended recovery from optic nerve trauma in the cat.

Authors:  Arthur J Weber; Christine D Harman
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-10-09       Impact factor: 4.799

9.  BDNF and HSP gene polymorphisms and their influence on the progression of primary open-angle glaucoma in a Polish population.

Authors:  Alicja Nowak; Jacek P Szaflik; Mira Gacek; Karolina Przybylowska-Sygut; Anna Kamińska; Jerzy Szaflik; Ireneusz Majsterek
Journal:  Arch Med Sci       Date:  2014-09-05       Impact factor: 3.318

Review 10.  Glaucoma -state of the art and perspectives on treatment.

Authors:  Anna Wójcik-Gryciuk; Małgorzata Skup; Wioletta J Waleszczyk
Journal:  Restor Neurol Neurosci       Date:  2015       Impact factor: 2.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.